Mergers & Acquisitions
Dec. 3, 2010
Pharmaceutical Acquisitions Dip, but Spending Rises
Big Pharma mega mergers dominated last year's nearly $200 billion pharmaceutical mergers and acquisitions marketplace.
Daily Journal Staff Writer
While the mega-mergers that dominated last year's nearly $200 billion pharmaceutical mergers and acquisitions marketplace have not continued apace, large pharmaceutical companies and their competitors are still showing a healthy appetite for biotechnology acquisitions to help fill future product pipelines as blockbuster drug patents expire.
That hunger for promising drugs, diagnostic tools and m...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In